Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
Author(s) -
Pierre Amarenco,
Stephen M. Davis,
E. Jones,
Ariel Cohen,
Wolf-Dieter Heiß,
Markku Kaste,
Cédric Laouénan,
Dennis Young,
Malcolm Macleod,
Geoffrey A. Donnan,
Christopher F. Bladin,
Brian R. Chambers,
Judith Frayne,
Graeme J. Hankey,
Christopher Levi,
Stephen Read,
Philippe Ravaud,
Turgut Tatlisumak,
Lauri Soinne,
Mika Laine,
Mikko Syvänne,
Pirkka Vikatmaa,
Mauri Lepäntalo,
France Mentré,
Simon Gosset,
Leonid Churilov,
T. de Broucker,
Pascal Favrole,
Jérôme Mawet,
Yves Mocquard,
Michaël Obadia,
Olivier Godefroy,
Hassan Hosseini,
Fernando Pico,
Pierre Garnier,
Marcel Malbec,
JeanFrançois Pinel,
Olivier Ille,
Xavier Vadamme,
Francisco Macian-Montoro,
Jérôme Servan,
François Viallet,
Thierry Rosolacci,
Patrick Lecoz,
Pierre Clavelou,
Olivier Detante,
TaeHee Cho,
D. Saudeau,
Patrik Michel,
Suzette D’Ombrogio,
David J. Serisier,
Jonathon Sturm,
Thomas Kimber,
Romesh Marcus,
Ray Schwartz,
Rob Helme,
David Blacker,
Jonathan Wood
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.004251
Subject(s) - medicine , clopidogrel , aspirin , warfarin , cardiology , stroke (engine) , aortic arch , aorta , atrial fibrillation , mechanical engineering , engineering
Severe atherosclerosis in the aortic arch is associated with a high risk of recurrent vascular events, but the optimal antithrombotic strategy is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom